Hosoi H, Hirosawa S, Yamamoto K, Ohkusa T, Aoki N
First Department of Internal Medicine, Faculty of Medicine, Tokyo Medical, and Dental University, Japan.
J Clin Gastroenterol. 1995 Jun;20(4):272-6. doi: 10.1097/00004836-199506000-00002.
Because endoscopic examinations are a crucial first step in the diagnosis of carcinomas, we have analyzed point mutations of the c-K-ras and p53 genes using biopsied samples. There is no previous report of such an approach, using only biopsied materials. We analyzed point mutations of the c-K-ras and p53 genes using 60 colorectal and 31 gastric tumor biopsy specimens. None of the gastric and seven of the colorectal tumors had mutations of the c-K-ras gene. p53 gene mutations were detected in six gastric carcinomas [two out of 11 intramucosal carcinomas (18.2%) and four out of 11 invasive carcinomas (36.4%)]. Eight of 15 invasive colorectal carcinomas (53.3%) showed point mutations in the p53 gene. Although point mutation frequencies in this study were relatively low when compared with previous reports in which surgical samples were used, our study shows that biopsied specimens are adequate and useful for analysis of gene point mutations.
由于内镜检查是癌症诊断的关键第一步,我们使用活检样本分析了c-K-ras和p53基因的点突变。此前尚无仅使用活检材料进行此类研究的报道。我们使用60份结直肠肿瘤活检标本和31份胃肿瘤活检标本分析了c-K-ras和p53基因的点突变。胃肿瘤中无一例c-K-ras基因突变,结直肠肿瘤中有7例存在该基因突变。在6例胃癌中检测到p53基因突变[11例黏膜内癌中有2例(18.2%),11例浸润性癌中有4例(36.4%)]。15例浸润性结直肠癌中有8例(53.3%)p53基因存在点突变。尽管与之前使用手术样本的报道相比,本研究中的点突变频率相对较低,但我们的研究表明,活检标本足以用于基因点突变分析且很有用。